Health Sciences

Putting biomedical research advances within reach

Treatments and vaccines are only useful in the hands of the people who need them, and Penn Medicine is working toward better access and equity for biomedical innovations.

Karen L. Brooks for Penn Medicine Magazine

In the News

The New York Times

What to know about Paxlovid rebound 

E. John Wherry of the Perelman School of Medicine says that it’s hard to get real-world data on COVID treatments because many people who have a rebound are unlikely to tell their doctors.



An overdose drug is finally over-the-counter. Is that enough to stop the death toll?

Shoshana Aronowitz of the School of Nursing says that over-the-counter Narcan is a baby step in the right direction, not a game changer.


Fox 29 (Philadelphia)

Sex for 62 to 72-year-olds could help prevent dementia, study shows

The research of Mike Cirigliano of the Perelman School of Medicine confirms sexual activity is a form of physical exercise.


Associated Press

Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works

Holly Fernandez Lynch of the Perelman School of Medicine says that lowered FDA standards send a message to the drug industry that they don’t have to prove their medication works.


Women’s Health

What happens when you stop taking Ozempic? Doctors explain the long- and short-term effects

Jena Shaw Tronieri of the Perelman School of Medicine explains why missing a dose of Ozempic is no reason to panic.